Dr. Scheller Cosmetics AG
Dr. Scheller Cosmetics: The company is staying fundamentally on course
Ad hoc announcement §15 WpHG
6-month report as of June 30, 2005
Dr. Scheller Cosmetics: The company is staying fundamentally on course
Ad hoc announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————
Eislingen, July 28, 2005: The positive development also continued in the
second quarter despite the extremely difficult market environment. Company’s
total sales grew by 5.6% to around EUR41 million. The growth was mainly driven
by foreign markets. As a result of the increase in inventories relating to
the delivery of a major customer and despite a substantially lower number of
employees, operating income rose by more than 16% to around EUR43 million.
Although a significant write-down of around EUR800 was taken on current
assets, gross earnings increased slightly more than sales, by 5.9%.
Marketing expenses in relation to sales for the first six months of the year
are above the budget estimate owing to the focus of the campaigns in the first
half of the year and will decrease correspondingly to the year-end. Personnel
costs fell year-on-year by around EUR1 million, which is also due to the
reversal of accruals for overtime and time off. Other operating income is
primarily influenced by the one-off reversal of accruals for pensions.
Due to the ongoing negative financial development of the Polish company, we
decided to write off the shareholding which results in a corresponding amount
totalling EUR630 thousand under Write-downs. This enables us to make a new
decision about the development of the Polish market. From today’s point of
view no additional material risks are expected from the shareholding.
Consequently, EBIT and EBT are still up around EUR1.5 million on the previous
year. The same also applies to profit after taxes.
Despite the one-off effects described that impacted half-year earnings in net
terms by approximately EUR1.1 million, from today’s point of view we continue
to expect that we will achieve EBT of around EUR2 million by the end of the
year.
The Management Board
Dr. Scheller Cosmetics AG
Schillerstraße 21-27
73054 Eislingen/Fils
Deutschland
ISIN: DE0007201303
WKN: 720130
Listed: Amtlicher Markt in Frankfurt (Prime Standard) und Stuttgart;
Freiverkehr in Berlin-Bremen, Düsseldorf und München
End of ad hoc announcement (c)DGAP 28.07.2005
Issuer’s information/explanatory remarks concerning this ad hoc announcement:
KEY RATIOS
JANUARY 1 to June 30
Jan. 1, 05- Jan. 1, 04-
Jun. 30, 05 Jun. 30, 04
EUR k EUR k
Sales 40,993 38,803
Return on sales (%) 1.1 -2.93
EBITDA 3,240 1,201
EBIT 1,072 -519
EBT 509 -1,054
Employees 375 424
Cash flow 692 2,943
Investments 1,181 1,240
Depreciation and 2,168 1,720
amortization
DVFA/SG result 766 -1,136
Earnings per share 0.12 -0.17
based on DVFA/SG (EUR)
End of message (c)DGAP
281007 Jul 05
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden